ALS progression varies dramatically between patients with no current way to predict outcomes, making personalized treatment planning nearly impossible for doctors and families. Machine learning models analyzing blood tests, clinical scores, and stem cell data can now identify top predictors of ALS progression, with findings validated across both Western and Asian populations.
Singapore neurologist harnesses AI to predict individual ALS progression patterns
ALS is a progressive fatal disease affecting 250-400 people in Singapore; patients face unpredictable deterioration and loss of muscle control, though some Asian patients live twice as long as Western counterparts.